Sources & Citations

These are the main references currently informing the awareness, statistics, myth-busting, and treatment guidance on this site. The goal is to keep the information compassionate, readable, and grounded in credible sources.

Source 1

National Institute of Mental Health (NIMH)

Used for prevalence, treatment, and high-level diagnostic context.

Visit Source
  • Past-year prevalence of BPD in U.S. adults: 1.4%.
  • Sex and race were not found to be associated with personality disorder prevalence.
  • NIMH also describes BPD as a serious mental illness affecting emotion regulation, impulsivity, and relationships.
https://www.nimh.nih.gov/health/topics/borderline-personality-disorder

Source 2

NewYork-Presbyterian Health Matters

Used for BPD vs. bipolar distinctions, symptom patterns, and treatment approaches.

Visit Source
  • Describes dysregulation across emotional, behavioral, cognitive, interpersonal, and self domains.
  • Explains black-and-white thinking and fear of abandonment in practical terms.
  • Summarizes DBT and transference-focused psychotherapy in accessible language.
https://healthmatters.nyp.org/understanding-difference-bipolar-borderline-personality-disorder/

Source 3

Revive Research Institute

Used to explain splitting, idealization, devaluation, and real-world relationship patterns.

Visit Source
  • Frames splitting as black-and-white thinking rather than manipulation.
  • Provides concrete examples of idealization and devaluation in everyday relationships.
  • Notes that episodes can last minutes, repeat throughout a day, or persist longer without coping tools.
https://www.reviveresearch.org/blog/borderline-personality-disorder-splitting/

Source 4

PMC / Clinical Review on BPD Medication Use

Used for medication context and why therapy remains the central treatment approach.

Visit Source
  • No medication is FDA-approved specifically for BPD core symptoms.
  • Medication should be limited to severe comorbid conditions or acute crises when needed.
  • Highlights the risks of polypharmacy despite weak evidence for routine use.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10786009/

Source 5

NAMI: Why Borderline Personality Disorder is Misdiagnosed

Used for misdiagnosis context and public education around stigma.

Visit Source
  • BPD is one of the most commonly misdiagnosed mental health conditions.
  • NAMI cites evidence that BPD is often mistaken for Bipolar II.
  • Helps explain why inaccurate diagnosis delays the right treatment and reinforces stigma.
https://www.nami.org/blog/why-borderline-personality-disorder-is-misdiagnosed/

Source 6

Borderline in the ACT: BPD Myths and Facts

Used for myth-busting, especially around gender and stigma.

Visit Source
  • Challenges the myth that only women have BPD.
  • Notes the currently observed 3:1 diagnosis ratio while also explaining how diagnostic bias can shape that picture.
  • Reinforces that people with BPD are genuinely suffering and deserve appropriate support.
https://www.borderlineintheact.org.au/living-with-bpd/bpd-myths-and-facts/